# Functional foods and nutraceuticals

Personalized-nutrition platforms, postbiotic ingredient innovation and challenger clean-label supplement brands are reshaping functional foods from a generic wellness category into claims-substantiated, life-stage-targeted products — with consolidation already underway (Hindustan Unilever's $90M OZiva acquisition).

Source: https://en.bioecon.ru/technology/functional-foods-nutraceuticals/
Updated: 2026-08-18



## Overview and value chain

Markers: [EC: EU Health Claims Regulation (EC) 1924/2006 — functional-food claim substantiation | OECD: Food systems | Regulator: FDA (USA), EFSA (EU)]

Functional foods and nutraceuticals cover food and supplement products
engineered to deliver a specific, substantiated health benefit beyond basic
nutrition — immunity, healthy aging, gut health — rather than a generic
wellness claim. The category's center of gravity is shifting from
one-size-fits-all supplements toward personalization: Danone's Singapore
D-Lab is applying AI and digital tools to healthy-ageing nutrition and
screening, and industry surveys identify a broader "MegaTrend" shift from
generic offerings to nutrition that responds to an individual's own data.
ADM is positioning postbiotics specifically as a next-generation ingredient
for healthy aging across mood, sleep and metabolism, while Amway's Nutrilite
brand continues to build immunity-support formulations that combine
traditional herbal actives (turmeric, licorice) with vitamin C. Consolidation
is already reshaping the challenger-brand tier: Hindustan Unilever agreed to
fully acquire India's OZiva, a clean-label protein and women's-health
supplement brand, for roughly $90 million in February 2026.

Key directions of functional foods and nutraceuticals:
1. **Personalized nutrition platforms (Personalized Nutrition Platforms):**
   AI- and data-driven tools (nutrigenetics, gut-microbiome profiling)
   tailoring a functional-food or supplement recommendation to an individual.
2. **Postbiotic and next-generation biotic ingredients (Postbiotic
   Ingredients):** non-living microbial-derived ingredients positioned for
   specific outcomes (healthy aging, mood, sleep, metabolism) beyond classic
   probiotics.
3. **Traditional-herbal/vitamin combination formulations (Traditional-
   Herbal/Vitamin Combination Formulations):** blending long-established
   botanicals with vitamins into a single immunity- or wellness-targeted
   product.
4. **Challenger clean-label brand consolidation (Challenger Clean-Label
   Brand Consolidation):** large incumbents acquiring fast-growing,
   digitally native supplement brands rather than building the same
   positioning in-house.

### Sectoral value chain

```
[health-benefit target] ──> [ingredient/formulation R&D] ──> [claim substantiation] ──> [product formulation]
                                                                     │
                                                             (regulatory
                                                              claim review)
                                                                     │
                                                                     ▼
[retail/DTC sale] <─── [brand positioning] <────────────────────────┘
```

### Value chain levels

| Level | Description | Key inputs/outputs |
|:---|:---|:---|
| **Health-Benefit Target** | selecting the specific outcome to address (immunity, healthy aging, gut health) | **In:** market/clinical need. **Out:** target health claim. |
| **Ingredient/Formulation R&D** | selecting or developing the active ingredient(s) | **In:** candidate actives (postbiotics, botanicals, vitamins). **Out:** formulation. |
| **Claim Substantiation** | generating the clinical/scientific evidence behind the health claim | **In:** formulation, study data. **Out:** substantiation dossier. |
| **Product Formulation** | finalizing the consumer product (food, drink, capsule) | **In:** substantiated ingredient. **Out:** finished product. |
| **Regulatory Claim Review** | clearing the health claim with FDA or under EU Regulation 1924/2006 | **In:** substantiation dossier. **Out:** approved claim. |
| **Retail/DTC Sale** | selling through retail or direct-to-consumer channels | **In:** approved product. **Out:** revenue. |

Cross-cutting technologies of the sector:
- **Nutrigenetic/microbiome personalization (Nutrigenetic/Microbiome Personalization):** integrating an individual's genetic or gut-microbiome data into a product or shopping recommendation.
- **Postbiotic ingredient standardization (Postbiotic Ingredient Standardization):** producing non-living, microbial-derived ingredients with consistent, claims-ready composition.
- **Health-claim substantiation pipelines (Health-Claim Substantiation Pipelines):** structured clinical/scientific evidence generation designed specifically to clear a regulator's claim-approval bar.

---

## US

The US hosts both a long-established herbal-nutraceutical brand and a
global ingredient supplier pivoting toward next-generation biotic ingredients.

### postbiotic ingredient innovation, herbal/vitamin immunity formulations, healthy-aging positioning
- **ADM:** positions postbiotics as a next-generation biotic ingredient for healthy-aging functional foods, targeting mood, sleep and metabolism outcomes alongside its broader protein-ingredient innovation.
- **Amway Nutrilite:** builds immunity-support formulations combining traditional herbal actives (turmeric, licorice, Amalaki/Vibhitaki/Haritaki) with vitamin C, alongside concentrated fruit-and-vegetable phytonutrient products.

---

## CN

Public information on a dedicated Chinese functional-foods/nutraceuticals
originator distinct from the region's broader supplement manufacturing base
was not confirmed in this pass; the section stays at the policy level.

### functional-food market research activity, nanoencapsulation research, no confirmed flagship originator
- **Active market-research interest:** Chinese industry research reports track functional-food market size and growth forecasts, reflecting significant commercial interest in the category.
- **Nanoencapsulation research base:** academic work on nanoencapsulation of nutraceuticals for improved stability and bioavailability is active, ahead of a confirmed flagship commercial originator in this specific pass.
- **No confirmed flagship originator:** a Chinese company matching the personalization/postbiotic positioning seen in the US/EU leaders was not confirmed via live sources in this pass.

---

## EU

The EU is applying AI and digital tools to personalize functional nutrition
around specific life stages, anchored by a health-claim regulation that
gates every functional-food claim made in the market.

### AI-driven personalized nutrition, healthy-ageing screening tools, EU health-claim substantiation
- **Danone Nutricia Research:** its Singapore D-Lab applies AI and digital capabilities to develop health-screening tools and nutrition solutions supporting healthy ageing, part of a broader industry shift toward nutrigenetics- and microbiome-informed personalization.
- **Personalization as a stated industry MegaTrend:** industry trend analysis identifies the shift from generic functional-nutrition offerings to individually responsive products as a defining 2026 direction.
- **EU Regulation (EC) 1924/2006:** requires every functional-food health claim to be scientifically substantiated and formally authorized before use in EU marketing.

---

## Leading companies and research institutes

| Company / Institute | Country | Key products / platforms | Tech features | Status 2026 |
|:---|:---|:---|:---|:---|
| **Danone Nutricia Research** | 🇫🇷 France | *D-Lab personalized nutrition* | AI/digital healthy-ageing screening tools | Commercial |
| **Amway Nutrilite** | 🇺🇸 USA | *Triple Protect, herbal immunity range* | traditional herbal actives + vitamin C combinations | Commercial |
| **ADM** | 🇺🇸 USA | *Postbiotic functional-food ingredients* | next-generation biotic for healthy aging | Commercial |
| **OZiva** | 🇮🇳 India | *Clean-label protein & women's health* | acquired by Hindustan Unilever for ~$90M (Feb 2026) | Commercial |

---

## Tech stack and innovations

The stack combines personalization data with claims-grade ingredient science.

1. **AI-driven nutrition personalization (AI-Driven Nutrition Personalization):**
   - digital tools integrate nutrigenetic and gut-microbiome data to tailor a nutrition or shopping recommendation to an individual.
   - case: Danone's D-Lab applies AI and digital capabilities specifically to healthy-ageing screening and nutrition solutions.
2. **Postbiotic ingredient engineering (Postbiotic Ingredient Engineering):**
   - non-living, microbial-derived ingredients are standardized and positioned for specific outcomes beyond classic live-probiotic claims.
   - case: ADM backs postbiotics specifically to drive healthy-aging innovation across mood, sleep and metabolism claims.
3. **Challenger-brand claims positioning (Challenger-Brand Claims Positioning):**
   - digitally native brands build a clean-label, claims-specific position (protein, women's health) that becomes an acquisition target for incumbents.
   - case: Hindustan Unilever's ~$90 million acquisition of OZiva brought a clean-label protein and women's-health brand directly into an incumbent's portfolio.

---

## Value chains and production pipelines

### Industrial pipeline of a claims-substantiated functional food (EU Health Claims Regulation)

```
┌───────────────────────────┐      ┌───────────────────────────┐
│ 1. Health-benefit target  │ ───> │ 2. Ingredient/formulation R&D│
└───────────────────────────┘      └───────────────────────────┘
                                                 │
                                                 ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 4. Product formulation    │ <─── │ 3. Claim substantiation   │
└───────────────────────────┘      └───────────────────────────┘
              │
              ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 5. Regulatory claim review│ ───> │ 6. Retail/DTC launch      │
└───────────────────────────┘      └───────────────────────────┘
```

#### Stage 1: Health-benefit target
A specific outcome — immunity, healthy aging, gut health, women's health — is selected as the product's target claim.

#### Stage 2: Ingredient/formulation R&D
Active ingredients (postbiotics, herbal actives, vitamins) are selected or developed to address the target outcome.

#### Stage 3: Claim substantiation
Clinical or scientific evidence is generated to support the specific health claim being made.

#### Stage 4: Product formulation
The substantiated ingredient is finalized into a food, drink or supplement product format.

#### Stage 5: Regulatory claim review
The health claim clears FDA review or EU Regulation 1924/2006 authorization before it can be marketed.

#### Stage 6: Retail/DTC launch
The product reaches consumers through retail or direct-to-consumer channels, with brand positioning increasingly a driver of acquisition activity in the category.

